Ruiwen Zhang

Cytowane przez

	Wszystkie	Od 2019
Cytowania	18378	5449
h-indeks	74	39
i10-indeks	205	118

1200

600

300

900

19951996199719981999200020012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023202465 87 155 238 217 246 263 323 431 446 476 453 555 544 605 600 636 759 783 880 967 1086 954 948 894 1140 1130 1019 940 324

Dostęp publiczny

Wyświetl wszystko

93 artykuły

8 artykułów

dostępne

niedostępne

Objęte finansowaniem

Współautorzy

Jiang-Jiang QinProfessor, HIM, Chinese Academy of SciencesZweryfikowany adres z ucas.ac.cn
Robert B. DiasioMayo Clinic Cancer CenterZweryfikowany adres z mayo.edu
Subhasree NagTexas Tech University Health Sciences Center, Pacific Northwest National LaboratoryZweryfikowany adres z ttuhsc.edu
sukesh vorugantiUT Southwestern Medical Center (Sr. Research Associate)Zweryfikowany adres z ttuhsc.edu
Qiuyin CaiVanderbilt University Medical CenterZweryfikowany adres z vanderbilt.edu
Van Meir, Erwin G.Professor of Neurosurgery and Hematology & Medical Oncology, Emory UniversityZweryfikowany adres z emory.edu
Gautam PrasadGoogleZweryfikowany adres z google.com
Horrick SharmaSWOSUZweryfikowany adres z swosu.edu
Sharad SharmaPrincipal Scientist, Boehringer IngelheimZweryfikowany adres z boehringer-ingelheim.com
SUSHANTA SARKARAppalachian College of PharmacyZweryfikowany adres z students.acp.edu
Snehal Padhye Ph.D. MBACharles River LaboratoriesZweryfikowany adres z crl.com
Oluf Dimitri RøeMD PhD NTNU, NorwayZweryfikowany adres z ntnu.no
T.-C. HeMolecular Oncology Laboratory, The University of Chicago Medical CenterZweryfikowany adres z bsd.uchicago.edu
Stephen BarnesUniversity of Alabama at BirminghamZweryfikowany adres z uab.edu
Xiaolin ZiProfessor of Urology, Pharmacology and Pharmaceutical SciencesZweryfikowany adres z uci.edu
Feng WangThe Chinese University of Hong KongZweryfikowany adres z cuhk.edu.hk
Evrim GurpinarCancer Research UK Beatson InstituteZweryfikowany adres z beatson.gla.ac.uk
Giampaolo TortoraMedical Oncology- Fondazione Policlinico Universitario Gemelli-IRCCS RomaZweryfikowany adres z policlinicogemelli.it
Veronika KozlovskayaThe University of Alabama at BirminghamZweryfikowany adres z uab.edu
Eugenia KharlampievaProfessor of Polymer Chemistry at Univ. of Alabama at BirminghamZweryfikowany adres z uab.edu

Obserwuj

Ruiwen Zhang

Professor of Pharmacology and Toxicology, Robert L. Boblitt Endowed Professor in Drug Discovery

Zweryfikowany adres z central.uh.edu

cancer pharmacology pharmaceutical sciences


Tytuł Sortuj wg cytatów Sortuj wg roku Sortuj wg tytułu	Cytowane przez Cytowane przez	Rok
Dihydropyrimidine dehydrogenase activity in human peripheral blood mononuclear cells and liver: population characteristics, newly identified deficient patients, and clinical … Z Lu, R Zhang, RB Diasio Cancer research 53 (22), 5433-5438, 1993	485	1993
The MDM2-p53 pathway revisited S Nag, J Qin, KS Srivenugopal, M Wang, R Zhang Journal of biomedical research 27 (4), 254, 2013	422	2013
Experimental therapy of hepatoma with artemisinin and its derivatives: in vitro and in vivo activity, chemosensitization, and mechanisms of action J Hou, D Wang, R Zhang, H Wang Clinical cancer research 14 (17), 5519-5530, 2008	412	2008
In vitro anti-cancer activity and structure–activity relationships of natural products isolated from fruits of Panax ginseng W Wang, Y Zhao, ER Rayburn, DL Hill, H Wang, R Zhang Cancer chemotherapy and pharmacology 59, 589-601, 2007	396	2007
Anti-inflammatory agents for cancer therapy ER Rayburn, SJ Ezell, R Zhang Molecular and cellular pharmacology 1 (1), 29, 2009	394	2009
Method of down-regulating gene expression S Agrawal, RB Diasio, R Zhang US Patent 5,591,721, 1997	366*	1997
Curcumin, a dietary component, has anticancer, chemosensitization, and radiosensitization effects by down-regulating the MDM2 oncogene through the PI3K/mTOR/ETS2 pathway M Li, Z Zhang, DL Hill, H Wang, R Zhang Cancer research 67 (5), 1988-1996, 2007	362	2007
Ginsenosides as Anticancer Agents: In vitro and in vivo Activities, Structure–Activity Relationships, and Molecular Mechanisms of Action SA Nag, JJ Qin, W Wang, MH Wang, H Wang, R Zhang Frontiers in pharmacology 3, 25, 2012	352	2012
Wnt/β-catenin signaling pathway as novel cancer drug targets HH Luu, R Zhang, RC Haydon, E Rayburn, Q Kang, W Si, JK Park, ... Current cancer drug targets 4 (8), 653-671, 2004	351	2004
Mixed-backbone oligonucleotides as second generation antisense oligonucleotides: In vitro and in vivo studies S Agrawal, Z Jiang, Q Zhao, D Shaw, Q Cai, A Roskey, L Channavajjala, ... Proceedings of the National Academy of Sciences 94 (6), 2620-2625, 1997	343	1997
MDM2 and human malignancies: expression, clinical pathology, prognostic markers, and implications for chemotherapy E Rayburn, R Zhang, J He, H Wang Current cancer drug targets 5 (1), 27-41, 2005	331	2005
Ribosomal protein S7 as a novel modulator of p53–MDM2 interaction: binding to MDM2, stabilization of p53 protein, and activation of p53 function D Chen, Z Zhang, M Li, W Wang, Y Li, ER Rayburn, DL Hill, H Wang, ... Oncogene 26 (35), 5029-5037, 2007	315	2007
MDM2 is a negative regulator of p21WAF1/CIP1, independent of p53 Z Zhang, H Wang, M Li, S Agrawal, X Chen, R Zhang Journal of Biological Chemistry 279 (16), 16000-16006, 2004	299	2004
Dietary flavonoids, quercetin, luteolin and genistein, reduce oxidative DNA damage and lipid peroxidation and quench free radicals Q Cai, RO Rahn, R Zhang Cancer letters 119 (1), 99-107, 1997	288	1997
Antisense therapy targeting MDM2 oncogene in prostate cancer: Effects on proliferation, apoptosis, multiple gene expression, and chemotherapy Z Zhang, M Li, H Wang, S Agrawal, R Zhang Proceedings of the National Academy of Sciences 100 (20), 11636-11641, 2003	261	2003
Dihydroartemisinin induces apoptosis and sensitizes human ovarian cancer cells to carboplatin therapy T Chen, M Li, R Zhang, H Wang Journal of cellular and molecular medicine 13 (7), 1358-1370, 2009	254	2009
Synergistic activation of p53 by inhibition of MDM2 expression and DNA damage L Chen, S Agrawal, W Zhou, R Zhang, J Chen Proceedings of the National Academy of Sciences 95 (1), 195-200, 1998	251	1998
Antisense, RNAi, and gene silencing strategies for therapy: mission possible or impossible? ER Rayburn, R Zhang Drug discovery today 13 (11-12), 513-521, 2008	245	2008
Targeting the NFκB signaling pathways for breast cancer prevention and therapy W Wang, SA Nag, R Zhang Current medicinal chemistry 22 (2), 264-289, 2015	233	2015
Quercetin-nanostructured lipid carriers: Characteristics and anti-breast cancer activities in vitro M Sun, S Nie, X Pan, R Zhang, Z Fan, S Wang Colloids and Surfaces B: Biointerfaces 113, 15-24, 2014	232	2014

Nie można teraz wykonać tej operacji. Spróbuj ponownie później.

Prace 1–20

Cytowania rocznie

Powielone cytowania

Scalone cytowania

Dodaj współautorówWspółautorzy

Obserwuj

Cytowane przez

Współautorzy